These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31092073)

  • 21. Racial/ethnic disparities in magnesium sulfate neuroprotection: a subgroup analysis of a multicenter randomized controlled trial.
    Vilchez G; Dai J; Kumar K; Mundy D; Kontopoulos E; Sokol RJ
    J Matern Fetal Neonatal Med; 2018 Sep; 31(17):2304-2311. PubMed ID: 28612671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antenatal magnesium sulphate administration for fetal neuroprotection: a French national survey.
    Chollat C; Le Doussal L; de la Villéon G; Provost D; Marret S
    BMC Pregnancy Childbirth; 2017 Sep; 17(1):304. PubMed ID: 28903747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maternal side effects & fetal neuroprotection according to body mass index after magnesium sulfate in a multicenter randomized controlled trial.
    Vilchez G; Dai J; Lagos M; Sokol RJ
    J Matern Fetal Neonatal Med; 2018 Jan; 31(2):178-183. PubMed ID: 28056569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antenatal magnesium sulfate for both tocolysis and fetal neuroprotection in premature rupture of the membranes before 32 weeks' gestation.
    Jung EJ; Byun JM; Kim YN; Lee KB; Sung MS; Kim KT; Shin JB; Jeong DH
    J Matern Fetal Neonatal Med; 2018 Jun; 31(11):1431-1441. PubMed ID: 28391733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of intravenous magnesium in non-preeclamptic pregnant women: fetal/neonatal neuroprotection.
    Jacquemyn Y; Zecic A; Van Laere D; Roelens K
    Arch Gynecol Obstet; 2015 May; 291(5):969-75. PubMed ID: 25501980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time and sex dependent effects of magnesium sulphate on post-asphyxial seizures in preterm fetal sheep.
    Bennet L; Galinsky R; Draghi V; Lear CA; Davidson JO; Unsworth CP; Gunn AJ
    J Physiol; 2018 Dec; 596(23):6079-6092. PubMed ID: 29572829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnesium sulphate for preventing preterm birth in threatened preterm labour.
    Crowther CA; Brown J; McKinlay CJ; Middleton P
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD001060. PubMed ID: 25126773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Magnesium Sulphate for Eclampsia and Fetal Neuroprotection: A Comparative Analysis of Protocols Across Canadian Tertiary Perinatal Centres.
    De Silva DA; Sawchuck D; von Dadelszen P; Basso M; Synnes AR; Liston RM; Magee LA
    J Obstet Gynaecol Can; 2015 Nov; 37(11):975-87. PubMed ID: 26629718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antenatal magnesium sulfate is beneficial or harmful in very preterm and extremely preterm neonates: a new insight.
    Garg BD
    J Matern Fetal Neonatal Med; 2019 Jun; 32(12):2084-2090. PubMed ID: 29301419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus.
    Doyle LW; Crowther CA; Middleton P; Marret S
    Cochrane Database Syst Rev; 2007 Jul; (3):CD004661. PubMed ID: 17636771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial.
    Crowther CA; Hiller JE; Doyle LW; Haslam RR;
    JAMA; 2003 Nov; 290(20):2669-76. PubMed ID: 14645308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnesium Sulfate and Novel Therapies to Promote Neuroprotection.
    Jameson RA; Bernstein HB
    Clin Perinatol; 2019 Jun; 46(2):187-201. PubMed ID: 31010555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus.
    Doyle LW; Crowther CA; Middleton P; Marret S; Rouse D
    Cochrane Database Syst Rev; 2009 Jan; (1):CD004661. PubMed ID: 19160238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maternal adverse effects with different loading infusion rates of antenatal magnesium sulphate for preterm fetal neuroprotection: the IRIS randomised trial.
    Bain ES; Middleton PF; Yelland LN; Ashwood PJ; Crowther CA
    BJOG; 2014 Apr; 121(5):595-603. PubMed ID: 24387624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclo-oxygenase (COX) inhibitors for treating preterm labour.
    Reinebrant HE; Pileggi-Castro C; Romero CL; Dos Santos RA; Kumar S; Souza JP; Flenady V
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD001992. PubMed ID: 26042617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Antenatal Magnesium Sulfate on the Gut Function of Preterm (<32 weeks) Very Low Birth Weight Neonates: Experience from a Tertiary Institute in South India.
    Chandran S; Tergestina M; Ross B; Joshi A; Rebekah G; Kumar M
    J Trop Pediatr; 2021 May; 67(2):. PubMed ID: 34100090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain lesions in newborns exposed to high-dose magnesium sulfate during preterm labor.
    Mittendorf R; Dammann O; Lee KS
    J Perinatol; 2006 Jan; 26(1):57-63. PubMed ID: 16319938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prenatal treatment with magnesium sulphate: Initial clinical outcomes in pre-term infants less than 29 weeks and correlation with neonatal magnesium levels].
    García Alonso L; Pumarada Prieto M; González Colmenero E; Concheiro Guisán A; Suárez Albo M; Durán Fernández-Feijoo C; González Durán L; Fernández Lorenzo JR
    An Pediatr (Barc); 2017 Mar; 86(3):135-141. PubMed ID: 27282203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. School-age outcomes following a randomized controlled trial of magnesium sulfate for neuroprotection of preterm infants.
    Chollat C; Enser M; Houivet E; Provost D; Bénichou J; Marpeau L; Marret S
    J Pediatr; 2014 Aug; 165(2):398-400.e3. PubMed ID: 24837863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Second overview of relationships between antenatal pharmacologic magnesium sulfate and neurologic outcomes in children.
    Mittendorf R; Pryde PG; Roizen N
    J Perinat Med; 2004; 32(3):201-10. PubMed ID: 15188791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.